Skip to content
International News, Medical Health Aged Care

New initiative aims to improve sleep health for millions of people in India and Australia

Monash University 3 mins read

Researchers from Monash University have connected experts from India and Australia to help improve the quality of life for people affected by sleep disorders. 

Sleep researchers, physicians, representatives from professional sleep medicine associations and delegates from Apollo Hospitals met at a roundtable at Indraprastha Apollo Hospitals, New Delhi to strengthen engagement in health research.

The group will establish the Australia-India Sleep Health Collaborative Initiative to foster bilateral relationships and address mutual challenges in sleep health by promoting the implementation of sleep medicine clinics in India. There will also be a focus on developing innovative care models that integrate Ayurvedic principles with modern practices.

Professor Shantha Rajaratnam, Professor of Sleep and Circadian Medicine, Head of the School of Psychological Sciences, Monash University, Australia, co-hosted the meeting with Apollo Hospitals. Clinical Professor Garun Hamilton, Respiratory and Sleep Disorders physician at Monash Health, was also in attendance. Professor Rajaratnam said this collaborative and integrative approach presents a unique opportunity to address sleep disorders, such as insomnia and obstructive sleep apnea (OSA), and circadian rhythm disorders, on a global scale.

“This roundtable will strengthen Australia-India engagement in sleep and circadian health research by establishing a network of experts from both countries to facilitate ongoing collaboration and knowledge exchange,” Professor Rajaratnam said.

“Addressing this growing public health crisis requires a multifaceted approach. There is an urgent need for personalised healthcare models and evidence-based, non-pharmacological treatments.

“This underscores the profound impact of sleep and circadian rhythm disturbances on overall health and mortality risk, and the importance of including sleep health as a core component of a preventive health framework.”

Professor Anupam Sibal, Group Medical Director, Apollo Hospitals, Lt. Gen Dr Bipin Puri, Director Medical Services, Indraprastha Apollo Hospitals, New Delhi, along with their experts from Sleep Medicine and Apollo Clinical Innovation Group, co-hosted this roundtable discussion meeting.

Mr Rajiv Vasudevan, CEO Apollo AyurVAID Hospitals, led by his team of doctors Dr Zankhana Buch, Senior Consultant Physician, Dr Supraja Reddy, Senior Consultant Physical Medicine and Rehabilitation and Dr Meera Sathish, Senior Consultant Research, also attended the discussion meeting.

They were joined by Dr Himanshu Garg, Respiratory & Sleep Physician, Australia, Dr B.P Singh, Ex-President elect of South East Asian Academy of Sleep Medicine (SEAASM), Dr Shivani Swami, Secretary of SEAASM, Dr Pratibha Dogra, President elect of SEAASM, Dr Viny Kantroo, Senior Consultant, Respiratory Medicine Indraprastha Apollo Hospitals, New Delhi and others.

Other key outcomes of the discussions identified priority areas for collaborative research initiatives in sleep and circadian medicine, leveraging the diverse expertise of academics, physicians, healthcare providers, and industry professionals from both countries.

Why is this collaboration so important?

Research has shown that insufficient sleep is a critical public health concern with far-reaching consequences. Reduced sleep duration is associated with  at least seven of the 15 leading causes of death, including cardiovascular disease, hypertension, diabetes, cerebrovascular disease and accidents.

In India, sleep disorders have reached alarming levels, with recent studies indicating a substantial burden of insomnia and obstructive sleep apnea (OSA). Estimates suggest that approximately 52 million Indians of working age suffer from OSA, with 29 million experiencing moderate-to-severe cases.

Compounding this issue, an estimated 37 per cent of older adults in India experience insomnia highlighting the widespread nature of sleep disturbances across age groups.

-ENDS-

 

About the Monash Sleep Network

The Monash Sleep Network combines scientific and clinical expertise in sleep research within the Faculty of Medicine, Nursing and Health Sciences at Monash University, The Hudson Institute of Medical Research and the Clinical Sleep Laboratories at Monash Medical Centre, the Monash Children’s Hospital, the Alfred, Frankston, Box Hill and Epworth Hospitals.

The Monash Sleep Network enables multidisciplinary approaches to sleep research and education including paediatric and adult sleep medicine, chronobiology, pharmacology, psychology and physiology.

The Monash Sleep Network is committed to advancing knowledge in sleep medicine by conducting the highest quality basic, clinical and applied research, and to providing undergraduate, postgraduate and public education about sleep medicine.

For any further information regarding the Monash Sleep Network, visit here.  


Key Facts:

Ayurvedic approaches with modern sleep and circadian medicine.

  • There has been growing interest in integrating traditional Ayurvedic approaches with modern sleep medicine. 

  • Ayurveda is founded on a holistic approach to health and illness, considering them as outcomes of the intricate interaction between physical, physiological, spiritual and environmental factors. 

  • Its focus on prevention, health promotion and personalised care aligns closely with modern healthcare perspectives, which have shifted from merely managing diseases to emphasising health promotion and disease prevention. This holistic perspective aligns well with the complex, multifactorial nature of sleep disorders. 

  • Ayurvedic practices such as lifestyle modifications, dietary recommendations and herbal remedies may complement conventional treatments, potentially improving outcomes.


Contact details:

MEDIA ENQUIRIES 
Andrew Groves
Media and Communications Manager
E: [email protected]

 

Media

More from this category

  • Medical Health Aged Care
  • 08/12/2025
  • 10:11
BeOne Medicines Ltd.

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid…

  • Contains:
  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

  • Medical Health Aged Care, Seniors Interest
  • 08/12/2025
  • 08:56
Monash University

Men and women may need different medications to avoid broken bones

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.